Biotechnology EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds – Clearmind Medicine (NASDAQ:CMND) Read more
Stockmarkets Byron Allen submits $30 billion offer for Paramount Global, including debt Reuters via biedexmarkets.com Read more